Clinical trial
BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas
NCT00406601 · Istituto Clinico Humanitas, Other · Completed
Key facts
| NCT number | NCT00406601 |
|---|---|
| Title | BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas |
| Official title | Phase II Prospective Study With BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas, After Anthracycline-based Therapy |
| Lead sponsor | Istituto Clinico Humanitas, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma, Soft Tissue |
| Intervention type | Drug |
| Interventions | Sorafenib (BAY-43-9006) |
| Enrollment | 69 |
| Start date | Nov 1, 2006 |
| Primary completion | Jun 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Dec 4, 2006 |
| Last update posted | Sep 2, 2010 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: